ID: ALA4214931

Max Phase: Preclinical

Molecular Formula: C61H94N20O17S5

Molecular Weight: 1539.88

Molecule Type: Unknown

Representations

Canonical SMILES:  CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CSSC[C@H](NC(=O)CN)C(=O)N[C@@H](CSSC[C@@H](C(N)=O)NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N2

Standard InChI:  InChI=1S/C61H94N20O17S5/c1-7-30(4)47-59(96)75-39(48(63)85)23-100-102-25-41-55(92)73-37(21-82)52(89)72-36(17-33-20-65-28-67-33)60(97)80-13-8-10-43(80)56(93)78-46(29(2)3)58(95)77-42(26-103-101-24-40(53(90)76-41)69-45(84)18-62)54(91)71-35(16-32-19-64-27-66-32)51(88)68-31(5)49(86)70-34(12-15-99-6)50(87)74-38(22-83)61(98)81-14-9-11-44(81)57(94)79-47/h19-20,27-31,34-44,46-47,82-83H,7-18,21-26,62H2,1-6H3,(H2,63,85)(H,64,66)(H,65,67)(H,68,88)(H,69,84)(H,70,86)(H,71,91)(H,72,89)(H,73,92)(H,74,87)(H,75,96)(H,76,90)(H,77,95)(H,78,93)(H,79,94)/t30-,31-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,46-,47-/m0/s1

Standard InChI Key:  YOFFBQSXZXWXMF-HGBGRBMMSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 1539.88

Molecular Weight (Monoisotopic): 1538.5709

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Yu J, Zhu X, Harvey PJ, Kaas Q, Zhangsun D, Craik DJ, Luo S..  (2018)  Single Amino Acid Substitution in α-Conotoxin TxID Reveals a Specific α3β4 Nicotinic Acetylcholine Receptor Antagonist.,  61  (20): [PMID:30252466] [10.1021/acs.jmedchem.8b00967]

Source

Source(1):

• Scientific Literature